Multiple myeloma trials in Belarus
2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleAnti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma
- Where
- Minsk
- Age
- 18 years and over
- People
- 30
- Run by
- Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
See details and how to joinNCT07477912 - Phase 3Taking peopleA Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)
- Where
- Homyel
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- Biocad
See details and how to joinNCT07742215